Summary of findings 1: PLD with chemotherapy vs alternative combination chemotherapy
Progression‐free survival · platinum‐sensitive recurrent EOC
Summary of findings 1: PLD with chemotherapy probably leads to lower progression‐free survival (PFS) compared with alternative combination chemotherapy (moderate certainty).
1 finding from 1 review
- Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer 2023 · Cochrane Headline outcomes onlyHR 0.81 [0.74, 0.89]5 studies · 2006 participantsModerate